From Surviving to Metaviving: A New Rhetorical Formation in Metastatic Breast Cancer Patient Discourse

Author:   Julie Mengert
Publisher:   Bloomsbury Publishing Plc
ISBN:  

9781666973105


Pages:   136
Publication Date:   13 November 2025
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $150.00 Quantity:  
Add to Cart

Share |

From Surviving to Metaviving: A New Rhetorical Formation in Metastatic Breast Cancer Patient Discourse


Overview

Full Product Details

Author:   Julie Mengert
Publisher:   Bloomsbury Publishing Plc
Imprint:   Rowman & Littlefield Publishers
ISBN:  

9781666973105


ISBN 10:   1666973106
Pages:   136
Publication Date:   13 November 2025
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Chapter One: The Rhetoric of Metastatic Breast Cancer Chapter Two: A Theory and Methodology of Rhetorical Formations in an Online Message Board Chapter Three: The Dominant Rhetorical Formation in Breast Cancer Discourse: War Rhetoric Chapter Four: ‘I Guess I’ll Never Be a Survivor’: The Existing Rhetorical Formation for Metastatic Breast Cancer Chapter Five: From Surviving to Metaviving: Confronting Mortality through Breast Cancer Rhetoric Chapter Six: Promoting Rhetorical Changes for Women with Metastatic Breast Cancer Appendix Works Cited About the Author

Reviews

Metavivors are people living with—and dying from—metastatic breast cancer. Metaphors of war and survival, still dominant in breast-cancer discourse, are, if they are useful to anyone, not, in general, useful to them. Indeed, they may be harmful. Mengert engages with these metaphors, and, with nuance and care, goes beyond them to explore questions of breast-cancer rhetoric more broadly—what it is and what it can be: When, as happens increasingly, cancer becomes a chronic illness, how do we speak of it and why does that matter? * Judy Z. Segal, Professor Emerita, University of British Columbia, Canada *


Author Information

Julie Mengert is Collegiate Assistant Professor at Virginia Tech.

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

OCT_RG_2025

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List